Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-008554
Filing Date
2016-02-12
Accepted
2016-02-12 11:31:39
Documents
41
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctxr_10q.htm 10-Q 226636
2 CERTIFICATION ctxr_ex311.htm EX-31.1 8878
3 CERTIFICATION ctxr_ex321.htm EX-32.1 3433
  Complete submission text file 0001477932-16-008554.txt   1549843

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctxr-20151231.xml EX-101.INS 244935
5 XBRL TAXONOMY EXTENSION SCHEMA ctxr-20151231.xsd EX-101.SCH 26206
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctxr-20151231_cal.xml EX-101.CAL 27231
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctxr-20151231_def.xml EX-101.DEF 55917
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctxr-20151231_lab.xml EX-101.LAB 138675
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctxr-20151231_pre.xml EX-101.PRE 113062
Mailing Address 63 GREAT ROAD MAYNARD MA 01754
Business Address 63 GREAT ROAD MAYNARD MA 01754 (978) 938-0338
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55532 | Film No.: 161416336
SIC: 3714 Motor Vehicle Parts & Accessories